• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,787
2,308
2,237
1,865
1,727

COUNTRY

1,033
871
272
254
210

CATEGORIES

  • 858
  • 186
  • 681
  • 1,129
  • 399
  • 270
  • 255
  • 66
  • 382
  • 728
  • 1,341
  • 1,356
  • 626
  • 884
  • 1,708
  • 2,691
  • 507
  • 734
  • 0
  • 93

PRICE

7,470
12,515
20,278
26,510

PUBLISHED

2,927
3,792
8,317
26,510

PRODUCT TYPE

21,635
2,901
872
827
164
44
21
21
18
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Hemorrhage - Pipeline Review, H2 2013

Hemorrhage - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Hemorrhage - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

December 2013
FROM

Androgenic Alopecia - Pipeline Review, H2 2013

Androgenic Alopecia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Androgenic Alopecia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

December 2013
FROM

Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2013

Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

December 2013
FROM

Bacterial Conjunctivitis - Pipeline Review, H2 2013

Bacterial Conjunctivitis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Bacterial Conjunctivitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

December 2013
FROM

Tachycardia (Tachyarrhythmias) - Pipeline Review, H2 2013

'Tachycardia (Tachyarrhythmias) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Tachycardia...

December 2013
FROM

Vasomotor Symptoms of Menopause - Pipeline Review, H2 2013

Vasomotor Symptoms of Menopause - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Vasomotor Symptoms of Menopause - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

December 2013
FROM

Periodontitis - Pipeline Review, H2 2013

Periodontitis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Periodontitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

December 2013
FROM

Arterial Thrombosis - Pipeline Review, H2 2013

Arterial Thrombosis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Arterial Thrombosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

December 2013
FROM

Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2013

Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

December 2013
FROM

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2013

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2013', provides an overview of the indication’s...

December 2013
FROM

Tinnitus - Pipeline Review, H2 2013

Tinnitus - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Tinnitus - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

December 2013
FROM

Circadian Rhythm Sleep Disorders - Pipeline Review, H2 2013

Circadian Rhythm Sleep Disorders - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Circadian Rhythm Sleep Disorders - Pipeline Review, H2 2013', provides an overview of the indication’s...

December 2013
FROM

Gaucher's Disease - Pipeline Review, H2 2013

Gaucher's Disease - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Gaucher's Disease - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

December 2013
FROM

Mixed Dyslipidemia - Pipeline Review, H2 2013

Mixed Dyslipidemia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Mixed Dyslipidemia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

December 2013
FROM

Nonmelanomatous Skin Cancer - Pipeline Review, H2 2013

Nonmelanomatous Skin Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Nonmelanomatous Skin Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

December 2013
FROM

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2013

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2013', provides...

December 2013
FROM

Skin Infections - Pipeline Review, H2 2013

Skin Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Skin Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

December 2013
FROM

Cellulite - Pipeline Review, H2 2013

Cellulite - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Cellulite - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

December 2013
FROM

Degenerative Disc Disease - Pipeline Review, H2 2013

Degenerative Disc Disease - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Degenerative Disc Disease - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

December 2013
FROM

Heart Transplantation - Pipeline Review, H2 2013

Heart Transplantation - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Heart Transplantation - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

December 2013
FROM
Loading Indicator

Our Clients

Our clients' logos